Illumina Inc
ILMN: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| g&& | LOCK|H@kM | LOCK|!k<P!&M |
Illumina Earnings: Strong Instrument Sales and Growing AI Opportunities Boost 2026 Outlook
Illumina's second-quarter results included organic sales growth of just under 7% (up from 4% in the first quarter) and 10% adjusted EPS growth to $1.31, which was above FactSet consensus of $1.23. Management raised its 2026 outlook on these results.
